This is the authors' abstract. We don't add key points for this paper.
Fluorescent thiol labeling is a powerful technique for investigating peptide and protein functions, interactions, and cellular localization, offering minimal structural disruption due to the low natural abundance of cysteine residues. The high nucleophilicity of cysteine thiol groups further facilitates efficient and selective labeling. However, existing thiol‐labeling strategies, most commonly involving iodoacetamides, maleimides, or methanethiosulfonates (MTS), often suffer from limited selectivity, undesirable side reactions, and the instability of the resulting conjugates. To overcome these limitations, we developed three spectrally orthogonal MTS‐derived fluorescent labeling agents based on coumarin and BODIPY photoremovable protecting groups and a BODIPY thiosulfate water‐soluble analogue. Using conventional MTS chemistry, these agents form disulfide‐linked conjugates with thiols, which are subsequently converted into stable thioethers upon light‐induced sulfur extrusion. This two‐step approach significantly improves the stability of labeled conjugates, providing a robust and permanent method for fluorescent labeling of small molecules, peptides, and proteins. Our findings offer a promising strategy for precise fluorescent labeling in biological applications.
No takes yet. Share an insight, caveat, or question.
Wohlrábová et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: